glp-1 causing migraines Treatment with receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain Study finds GLP-1 drug cut

Current UK Guidance on GLP-1 Use During Lactation Current evidence regarding GLP-1 receptor agonist safety during breastfeeding is extremely limited , and UK regulatory guidance is clear: these medications should not be used during breastfeeding

Q: Top five category gainers in Health and Beauty Care Expanding beyond Health and Beauty Care, Beverage is another category with shifts in spend among GLP-1 weight loss users

Retatrutide is widely viewed as a potential next efficacy benchmark ahead of its expected 2027/28 launch

p = 0.042), although only a numerical trend for patients with microalbuminuria ( 30 to 9%: 2.4 vs